Skip to main content
Header logo
  • About Moberg Open link menu
    About Moberg
    • CEO Comments
    • Business Model
    • Board and Leadership
  • MOB-015
  • Sustainability
  • Investors Open link menu
    Investors
    • Results and Presentations
    • The share Open link menu
      The share
      • Major shareholders
      • Insider Trading
      • Financial Data
    • Analysts
    • Calender
    • Corporate governance Open link menu
      Corporate governance
      • Board of directors
      • Management
      • General shareholders meetings
      • Nomination committee
      • Auditors
      • Remuneration
      • Share-based incentive program
      • Articles of Association
    • Press releases
    • Prospectus
  • Media Open link menu
    Media
    • Image Archive
    • Press Releases
  • Contact
    • EN Current language English, click to switch language
    • SV Switch to Swedish
  • Please fill out this field
Close
Please fill out this field
img
Breadcrumbs
  • Home
  • Media

Media

Interview with CEO Anna Ljung
Link to video from November 11, 2025

Interview with CEO Anna Ljung

Link to video from November 11, 2025
Press releases Regulatory
More
2025-11-11
Moberg Pharma interim report January - September 2025
2025-11-05
Moberg Pharma and Karo Healthcare enter exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
2025-10-31
Moberg Pharma's Nomination Committee appointed
All press releases
2025-11-11
Moberg Pharma interim report January - September 2025
2025-11-05
Moberg Pharma and Karo Healthcare enter exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
2025-10-31
Moberg Pharma's Nomination Committee appointed
All press releases
Lab Microscope
IMAGE BANK
IMAGE BANK
media

Contact for press and media

Anna Ljung, CEO
Phone: +46 8 522 307 08

Email: [email protected]

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address: 
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address: 
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Sign up

Home
Moberg Pharma´s Interim report January - September 2024

Footer

  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Cookies
  • Copyright
  • Cookie settings
  • © Moberg Pharma AB (publ) 2025